ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
22 hedge funds and large institutions have $471K invested in Oncternal Therapeutics, Inc. Common Stock in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 6 closing their positions.
Holders
22
Holders Change
-4
Holders Change %
-15.38%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
4
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
VF
1
Virtu Financial
New York
|
$16K |
2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$3.73K |
3 |
3
UBS Group
Zurich,
Switzerland
|
$1.61K |
4 |
4
Renaissance Technologies
New York
|
$23.6K |
5 |
5
BlackRock
New York
|
$52.4K |